Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 2
1996 1
1999 1
2000 2
2003 1
2005 1
2008 6
2009 2
2011 1
2012 3
2013 3
2014 3
2015 1
2016 3
2017 1
2018 3
2019 3
2020 1
2022 5
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren's syndrome.
Huijser E, Bodewes ILA, Lourens MS, van Helden-Meeuwsen CG, van den Bosch TPP, Grashof DGB, van de Werken HJG, Lopes AP, van Roon JAG, van Daele PLA, Brkic Z, Dik WA, Versnel MA. Huijser E, et al. Among authors: van helden meeuwsen cg. Rheumatology (Oxford). 2022 Aug 3;61(8):3491-3496. doi: 10.1093/rheumatology/keac016. Rheumatology (Oxford). 2022. PMID: 35022662 Free PMC article.
Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical response.
Hamkour S, van der Heijden EH, Lopes AP, Blokland SLM, Bekker CPJ, Van Helden-Meeuwsen CG, Versnel MA, Kruize AA, Radstake TR, Leavis HL, Hillen MR, van Roon JA. Hamkour S, et al. Among authors: van helden meeuwsen cg. RMD Open. 2023 Aug;9(3):e002979. doi: 10.1136/rmdopen-2023-002979. RMD Open. 2023. PMID: 37532471 Free PMC article.
Targeted multiomics in childhood-onset SLE reveal distinct biological phenotypes associated with disease activity: results from an explorative study.
Wahadat MJ, van Tilburg SJ, Mueller YM, de Wit H, Van Helden-Meeuwsen CG, Langerak AW, Gruijters MJ, Mubarak A, Verkaaik M, Katsikis PD, Versnel MA, Kamphuis S. Wahadat MJ, et al. Among authors: van helden meeuwsen cg. Lupus Sci Med. 2023 Apr;10(1):e000799. doi: 10.1136/lupus-2022-000799. Lupus Sci Med. 2023. PMID: 37012057 Free PMC article.
Trained Immunity in Primary Sjögren's Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype.
Huijser E, van Helden-Meeuwsen CG, Grashof DGB, Tarn JR, Brkic Z, Huisman JMA, Wahadat MJ, van de Werken HJG, Lopes AP, van Roon JAG, van Daele PLA, Kamphuis S, Ng WF, Bekkering S, Joosten LAB, Dik WA, Versnel MA. Huijser E, et al. Among authors: van helden meeuwsen cg. Front Immunol. 2022 Jul 4;13:840751. doi: 10.3389/fimmu.2022.840751. eCollection 2022. Front Immunol. 2022. PMID: 35860283 Free PMC article.
Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren's syndrome.
Huijser E, Göpfert J, Brkic Z, van Helden-Meeuwsen CG, Jansen S, Mandl T, Olsson P, Schrijver B, Schreurs MWJ, van Daele PLA, Dik WA, Versnel MA. Huijser E, et al. Among authors: van helden meeuwsen cg. Rheumatology (Oxford). 2022 May 5;61(5):2156-2166. doi: 10.1093/rheumatology/keab688. Rheumatology (Oxford). 2022. PMID: 34505866 Free PMC article.
Gene signature fingerprints stratify SLE patients in groups with similar biological disease profiles: a multicentre longitudinal study.
Wahadat MJ, Schonenberg-Meinema D, van Helden-Meeuwsen CG, van Tilburg SJ, Groot N, Schatorjé EJH, Hoppenreijs EPAH, Hissink Muller PCE, Brinkman DMC, Dvorak D, Verkaaik M, van den Berg JM, Bouchalova K, Kamphuis S, Versnel MA. Wahadat MJ, et al. Among authors: van helden meeuwsen cg. Rheumatology (Oxford). 2022 Nov 2;61(11):4344-4354. doi: 10.1093/rheumatology/keac083. Rheumatology (Oxford). 2022. PMID: 35143620 Free PMC article.
Fatigue in Sjögren's Syndrome: A Search for Biomarkers and Treatment Targets.
Bodewes ILA, van der Spek PJ, Leon LG, Wijkhuijs AJM, van Helden-Meeuwsen CG, Tas L, Schreurs MWJ, van Daele PLA, Katsikis PD, Versnel MA. Bodewes ILA, et al. Among authors: van helden meeuwsen cg. Front Immunol. 2019 Feb 26;10:312. doi: 10.3389/fimmu.2019.00312. eCollection 2019. Front Immunol. 2019. PMID: 30863411 Free PMC article.
Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort.
Wahadat MJ, Qi H, van Helden-Meeuwsen CG, Huijser E, van den Berg L, van Dijk-Hummelman A, Göpfert JC, Heine A, Verkaaik M, Schreurs MWJ, Dik WA, Kamphuis S, Versnel MA. Wahadat MJ, et al. Among authors: van helden meeuwsen cg. Rheumatology (Oxford). 2023 Aug 1;62(8):2872-2879. doi: 10.1093/rheumatology/keac698. Rheumatology (Oxford). 2023. PMID: 36515466 Free PMC article.
43 results